Request for Proposal (RFP): Consultancy to support Treatment and Care for Adolescents Living with HIV: 2014/HTM/HIV/009

The WHO programme on HIV is located in the HIV, TB and Malaria Cluster (HTM). It is guided by the Global Health Strategy for HIV 2011-15. Its goals are consistent with getting to zero: UNAIDS Strategy 2011-15 and other international commitments as for example the Millennium Development Goals. The objective of the Department of HIV is to lead an effective, organisation wide HIV effort to support member states in the implementation of the strategy. The HIV Department (HQ/HIV) provides technical and strategic leadership in key technical areas, and leverages the capacity of other HQ departments to contribute to the broader HIV programme.

The consultant will support activities in two units of the HIV Department: Treatment and Care Unit (TAC) and Key Population and Innovative Prevention (KPP). She/He will assist WHO/HIV/TAC with Technical expert support to WHO’s work on developing normative guidance and provide technical assistance in the area of treatment and care for adolescents living with HIV. She/He will assist WHO/HIV/KPP with Technical support to WHO’s work on voluntary medical male circumcision and adolescent health.

The WHO/HIV/TAC unit ensures effective coordination with other HQ Departments, Regional Offices and key external collaborating partners in the area of HIV "Treatment and Care", and acts as a focal point for treatment and care related aspects of global implementation of Strategic Direction 1 "Optimize HIV prevention, diagnosis, treatment and care outcomes" and Strategic Direction 2 ‘Leverage broader health outcomes through HIV  responses of the Global Health Sector Strategy on HIV 2011-2015’.

The WHO/HIV/KPP unit is responsible for much of WHO’s work on HIV prevention. It focuses on key populations at greatest risk of HIV infection (sex workers, men who have sex with men and injection drug users) as well as other groups particularly vulnerable to infection, such as adolescents. It is also responsible for the Department’s work on new prevention technologies, principally male circumcision and pre-exposure prophylaxis or PrEP, and for HIV testing and counselling, including self-testing and its potential role in prevention and increased access to treatment and care.

Main activities and Deliverables:

Under the WHO/HIV/KPP unit:

1. Medical Male Circumcision (MMC) and Adolescent Sex and Reproductive Health (ASRH)

• Prepare the ASRH MC linkages work including the situation assessments and field testing of service delivery in the 2 selected African countries and provide technical advice to the ministry, as needed. Collaborate with other local and international consultants working on this project.
• Draft guidance on sustainable ASRH - MC programmes and services. The  format and content of the guidance will be specified and undertake the appropriate WHO processes (e.g. GRC).
• Based on the above, contribute to the strategic framework within which ASRH MC will be one component.
• Prepare agenda, report and meeting documents and communication on ASRH and MMC.
• Contribute to adolescent aspects of other guidance that is developed: the Use of devices guidance on the adolescent aspect, and monitoring with age disaggregation.

2. Values and Preferences

Under the WHOWHO/HIV/TAC unit:

3. Adolescent treatment and care

• Development of preparation of supporting documentation and background for 2015 ARV Guidelines.
• Provision of technical input to the preparatory work required for the revision of the WHO 2015 ARV Guidelines in the area of clinical management and service delivery. This includes contribution to the development of systematic reviews, assessment of ongoing research and collection of emerging clinical and programmatic data to inform clinical management and service delivery for adolescents living with HIV.
• Provision of technical input to the activities required by the “All-in” initiative in support of the scale up of prevention, treatment and care for adolescents affected and living with HIV.

The initial contract duration under this RFP is for 12 months and could be extended up to a maximum of 24 months depending on the needs for further consultancy work, and on funding availability.

Submission of proposals:

1. No later than 23 January 2015, 12:00 noon CET, the bidder shall complete and return by either email or hard copy to WHO (only when this step is completed the bidder is regarded as a prospective bidder):
   1. The enclosed “2014HTMHIV009_4_RFP Acknowledgement Form (Treatment and Care for Adolescents).pdf” form completed and signed as confirmation of the bidder's intention to submit a bona fide proposal and designate its representative to whom communications may be directed, including any addenda; and
   2. The enclosed “2014HTMHIV009_3_RFP Confidentiality Undertaking (Treatment and Care for Adolescents).pdf” form completed and signed.
2. No later than 23 January 2015, 12:00 noon CET, the bidder shall submit:
   1. A covering letter signed by the bidder or the respective authority when the bidder is not an individual.
   2. The Proposal (including, but not restricted to, technical and financial documents).
   3. The enclosed “2014HTMHIV009_5_RFP Acceptance Form (Treatment and Care for Adolescents).doc” form completed and signed.
   4. The enclosed “2014HTMHIV009_6_RFP Completeness Form (Treatment and Care for Adolescents).doc” form completed and signed.

All documents must be received by WHO at the address specified in section 4.8 “Sealing and marking of proposals” of the RFP no later than 23 January 2015, 12:00 noon CET.

• Email for submissions of forms and/or proposal: pdifin@who.int (use subject: Bid Ref 2014HTMHIV009)
• Mailing address for submission of proposal:

World Health Organization

­­­­Mr. Jerome Peron

HQ/HIV, PDI/FIN, D45034

Bid Ref: 2014HTMHIV009

20, Avenue Appia

CH-1211 Geneva 27

Switzerland

Refer to attached documents for additional information.

• Web Site: http://www.who.int/hiv

• Keywords: HIV AIDS, MALE CIRCUMCISION, MMC, ASRH, ADOLESCENT SEX, ARV

• Documents to be attached:

• 2014HTMHIV009_0_RFP Advert (Treatment and Care for Adolescents)_Revised.pdf REVISED
• 2014HTMHIV009_2_RFP ToRs (Treatment and Care for Adolescents)_ Revised.pdf REVISED
• 2014HTMHIV009_3_RFP Confidentiality Undertaking (Treatment and Care for Adolescents). pdf
• 2014HTMHIV009_4_RFP Acknowledgement Form (Treatment and Care for Adolescents)_ Revised. Pdf REVISED
• 2014HTMHIV009_5_RFP Acceptance Form (Treatment and Care for Adolescents).doc

2014HTMHIV009_6_RFP Completeness Form (Treatment and Care for Adolescents).doc